Herbal preparations can be problematic for a variety of reasons – but what role should pharmacists play? Use of herbal medicines is increasing in Western countries despite the potential risks, …

“I often work in holiday locations as a locum and am approached by customers who claim to be a doctor on holidays, usually working in a public hospital, and wanting …

“Over the last few week, I have had more than a few patients ask me why some medication comes in a 30-day pack e.g. Atacand & Crestor, but others they …

Allocations for $600m for pharmacy programs to be finalised within next two weeks Pharmacy Guild National President George Tambassis has reassured members that work is underway regarding the allocation of …

AJP chats with the multi-talented pharmacist and General Manager behind pharmacy.com.au 1. How did you go from pharmacy graduate to GM of a major online brand in the pharmacy space? The …

A Sydney pharmacy has achieved Runner Up in the local Better Business Awards for its “green” initiatives Nick Logan Pharmacist Advice in Artarmon, NSW, has placed Runner Up in the …

“Ever had a patient wanting to get enough until payday and then never returns for the balance or to pay?” Post a comment. Other current topics in the AJP Discussion …

Can you say it in 140 characters or less? These 20 top tweets range from informative and insightful to plain hilarious An old lady came into the pharmacy today and asked …

We have one of the most comprehensive national hepatitis programs in the Asia-Pacific, survey finds The Asia Pacific Viral Hepatitis Policy Survey released this week has revealed how prepared different governments …

When it comes to perception of ethics and honesty across professions, pharmacists have dropped down the ranks Health professionals have continued their domination of Australia’s most highly regarded professions. Australia’s …

A relatively new drug has been found to greatly reduce risk of cardiovascular and kidney disease – though it comes with risks of its own Canagliflozin (Invokana) is a SGLT2 …

In response to concerns about raising the screening starting age from 18 to 25, researchers have reviewed the risks As previously reported in the AJP, from December 2017 the biennial …